Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma Statistics

Total Valuation

LYEL has a market cap or net worth of $171.08 million. The enterprise value is -$231.01 million.

Market Cap	171.08M
Enterprise Value	-231.01M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

LYEL has 279.22 million shares outstanding. The number of shares has increased by 1.82% in one year.

Current Share Class	279.22M
Shares Outstanding	279.22M
Shares Change (YoY)	+1.82%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	3.21%
Owned by Institutions (%)	48.25%
Float	203.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.30
P/TBV Ratio	0.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.43, with a Debt / Equity ratio of 0.11.

Current Ratio	13.43
Quick Ratio	13.15
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.22% and return on invested capital (ROIC) is -20.00%.

Return on Equity (ROE)	-33.22%
Return on Assets (ROA)	-19.12%
Return on Capital (ROIC)	-20.00%
Revenue Per Employee	$281
Profits Per Employee	-$910,665
Employee Count	224
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.26% in the last 52 weeks. The beta is -0.46, so LYEL's price volatility has been lower than the market average.

Beta (5Y)	-0.46
52-Week Price Change	-70.26%
50-Day Moving Average	1.01
200-Day Moving Average	1.68
Relative Strength Index (RSI)	27.85
Average Volume (20 Days)	1,521,548

Short Selling Information

The latest short interest is 9.45 million, so 3.38% of the outstanding shares have been sold short.

Short Interest	9.45M
Short Previous Month	9.60M
Short % of Shares Out	3.38%
Short % of Float	4.64%
Short Ratio (days to cover)	6.15

Income Statement

In the last 12 months, LYEL had revenue of $63,000 and -$203.99 million in losses. Loss per share was -$0.80.

Revenue	63,000
Gross Profit	63,000
Operating Income	-216.26M
Pretax Income	-210.26M
Net Income	-203.99M
EBITDA	-196.60M
EBIT	-216.26M
Loss Per Share	-$0.80

Balance Sheet

The company has $440.55 million in cash and $58.58 million in debt, giving a net cash position of $402.08 million or $1.44 per share.

Cash & Cash Equivalents	440.55M
Total Debt	58.58M
Net Cash	402.08M
Net Cash Per Share	$1.44
Equity (Book Value)	530.70M
Book Value Per Share	2.07
Working Capital	416.53M

Cash Flow

In the last 12 months, operating cash flow was -$155.79 million and capital expenditures -$445,000, giving a free cash flow of -$156.23 million.

Operating Cash Flow	-155.79M
Capital Expenditures	-445,000
Free Cash Flow	-156.23M
FCF Per Share	-$0.56

Margins

Gross Margin	100.00%
Operating Margin	-343,273.02%
Pretax Margin	-323,792.06%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LYEL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.82%
Shareholder Yield	-1.82%
Earnings Yield	-119.24%
FCF Yield	-91.32%

Analyst Forecast

The average price target for LYEL is $1.00, which is 63.21% higher than the current price. The consensus rating is "Sell".

Price Target	$1.00
Price Target Difference	63.21%
Analyst Consensus	Sell
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LYEL has an Altman Z-Score of 0.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.39
Piotroski F-Score	1